Comparing DOXEPIN (cas 1668-19-5) cream to oral antihistamines for the treatment of itch in burn patients: A multi-center triple-blind randomized controlled trial
-
Add time:09/10/2019 Source:sciencedirect.com
BackgroundDOXEPIN (cas 1668-19-5) cream, an antihistaminic agent, has shown promising results in the treatment of pruritus in burn patients. However, its effectiveness has not been studied comprehensively.
We also recommend Trading Suppliers and Manufacturers of DOXEPIN (cas 1668-19-5). Pls Click Website Link as below: cas 1668-19-5 suppliers
Prev:Chapter 8 - Chiral Acyclic PNA Modifications: Synthesis and Properties
Next:Document headingTherapeutic rationale for low dose DOXEPIN (cas 1668-19-5) in insomnia patients) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research paperAntidepressant polypharmacy and the potential of pharmacokinetic interactions: DOXEPIN (cas 1668-19-5) but not mirtazapine causes clinically relevant changes in venlafaxine metabolism10/01/2019
- Physicochemical evaluation and non-isothermal kinetic study of the drug–excipient interaction between DOXEPIN (cas 1668-19-5) and lactose09/27/2019
- Clinical reviewDOXEPIN (cas 1668-19-5) for insomnia: A systematic review of randomized placebo-controlled trials09/26/2019
- Original Research ArticleHighly sensitive LC–MS/MS method to estimate DOXEPIN (cas 1668-19-5) and its metabolite norDOXEPIN (cas 1668-19-5) in human plasma for a bioequivalence study09/25/2019
- Document headingTherapeutic rationale for low dose DOXEPIN (cas 1668-19-5) in insomnia patients09/24/2019